Pinnacle Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $17.9M | Sell |
|
|||||
|
2024
Q4 | $12.1M | Sell |
|
|||||
|
2024
Q3 | $12.6M | Buy |
|
|||||
|
2024
Q2 | $11.7M | Sell |
|
|||||
|
2024
Q1 | $12M | Sell |
|
|||||
|
2023
Q4 | $12.6M | Sell |
|
|||||
|
2023
Q3 | $9.23M | Sell |
|
|||||
|
2023
Q2 | $11.7M | Sell |
|
|||||
|
2023
Q1 | $10.4M | Sell |
|
|||||
|
2022
Q4 | $10.3M | Sell |
|
|||||
|
2022
Q3 | $9.23M | Sell |
|
|||||
|
2022
Q2 | $11.8M | Sell |
|
|||||
|
2022
Q1 | $12.6M | Sell |
|
|||||
|
2021
Q4 | $11.3M | Sell |
|
|||||
|
2021
Q3 | $8.12M | Sell |
|
|||||
|
2021
Q2 | $9.21M | Buy |
|
|||||
|
2021
Q1 | $7.55M | Sell |
|
|||||
|
2020
Q4 | $7.86M | Sell |
|
|||||
|
2020
Q3 | $6.78M | Sell |
|
|||||
|
2020
Q2 | $7.08M | Buy |
|